Changes of tyrosine hydroxylase in parkinsonian brains and in the brains of MPTP-treated mice.
Nagatsu
T
T
Department of Biochemistry, Nagoya University School of Medicine, Japan.
D015632:1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine / Q000494:pharmacology*; D000818:Animals; D001921:Brain / Q000187:drug effects* / Q000473:pathology; D003342:Corpus Striatum / Q000187:drug effects; D006801:Humans; D051379:Mice; D010300:Parkinson Disease / Q000473:pathology*; D010302:Parkinson Disease, Secondary / Q000139:chemically induced* / Q000473:pathology; D011954:Receptors, Dopamine / Q000187:drug effects; D013378:Substantia Nigra / Q000187:drug effects; D014446:Tyrosine 3-Monooxygenase / Q000037:antagonists & inhibitors / Q000378:metabolism*
D011954:Receptors, Dopamine; D015632:1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; D014446:Tyrosine 3-Monooxygenase